Spots Global Cancer Trial Database for Sonazoid Enhanced Liver Cancer Trial for Early Detection
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Sonazoid Enhanced Liver Cancer Trial for Early Detection
Official Title: Sonazoid Enhanced Liver Cancer Trial for Early Detection
Study ID: NCT00822991
Study Description
Brief Summary: The aim of this study is to prove usefulness of contrast-enhanced ultrasound (CE-US) using Sonazoid (TM) in the early detection of HCC as compared with conventional B-mode ultrasound (B-mode US) for hepatitis virus related cirrhosis, who are defined as super high-risk patients for hepatocarcinogenesis,Furthermore, to analyze whether early detection of HCC by CE-US has a survival benefit than that by B-mode US.
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Kinki University School of Medicine, Department of Gastroenterology and Hepatology, Osaka-Sayama, Osaka, Japan
Contact Details
Name: Masatoshi Kudo, professor
Affiliation: Kindai University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
